ABSTRACT: APEX is an engineered peroxidase that catalyzes the oxidation of a wide range of substrates, facilitating its use in a variety of applications from subcellular staining for electron microscopy to proximity biotinylation for spatial proteomics and transcriptomics. To further advance the capabilities of APEX, we used directed evolution to engineer a split APEX tool (sAPEX). A total of 20 rounds of fluorescence activated cell sorting (FACS)-based selections from yeastdisplayed fragment libraries, using 3 different surface display configurations, produced a 200-amino-acid N-terminal fragment (with 9 mutations relative to APEX2) called "AP" and a 50-amino-acid C-terminal fragment called "EX". AP and EX fragments were each inactive on their own but were reconstituted to give peroxidase activity when driven together by a molecular interaction. We demonstrate sAPEX reconstitution in the mammalian cytosol, on engineered RNA motifs within a non-coding RNA scaffold, and at mitochondria− endoplasmic reticulum contact sites.
■ INTRODUCTION
APEX2 is an engineered variant of soybean ascorbate peroxidase that, unlike the commonly used horseradish peroxidase (HRP), retains activity when expressed in the cytosol, mitochondria, and other reducing environments within the cell. 1, 2 This feature of APEX2, in addition to its versatile ability to catalyze the H 2 O 2 -dependent one-electron oxidation of a wide array of small-molecule substrates, has led to its widespread use for a variety of applications, including proteomic mapping of organelles, 2−6 proximity tagging of protein interactomes, 7−9 spatial mapping of cellular RNA, 10 electron microscopy, 1,11−16 H 2 O 2 sensing, 17 and protein topology determination. 1, 2, 16 In general, the use of APEX2 begins with fusing it to a protein or peptide to target it to a subcellular region or macromolecular complex of interest. For instance, we have targeted APEX2 to the outer mitochondrial membrane (OMM) and the endoplasmic reticulum membrane (ERM) of mammalian cells by fusing the APEX2 gene to transmembrane domains of proteins native to these subcellular locations. 4, 16 These constructs were used for both EM 16 and proteomic analysis 4 of the OMM and ERM. While this APEX2 fusion strategy has enabled the study of many cellular regions and organelles, there are numerous compartments and structures to which APEX2 cannot be selectively targeted. For example, there is great interest in the biology of organelleorganelle contact sites, such as the junctions between mitochondria and ER, which participate in calcium signaling, 18, 19 lipid synthesis, 20−23 and mitochondrial fission. 24 , 25 Yet all candidate protein fusions that could potentially target APEX2 to these contact sites, such as to the proteins Drp1, 24 Mfn2, 26−28 SYNJ2BP1, 4 and PDZD8, 29 would also target the peroxidase to locations outside of mito-ER contacts, such as throughout the cytosol, 30 along the cytoskeleton, 31 or over the entire OMM. 4 Another application for which the conventional APEX2 genetic fusion strategy may be unsuitable is profiling the interactomes of specific cellular RNAs. While several robust methods can identify RNAs that interact with specific proteins of interest, 32−34 the converse problem (identifying proteins that interact with a particular RNA) is much more challenging using existing methods. One could envision fusing APEX2 to a high-affinity RNA-binding protein (RBP; for example, the bacteriophage MS2 coat protein), 35 allowing the peroxidase to be ectopically targeted to transcripts that are tagged with that RBP's cognate RNA motif. However, a major concern would An acid coil was co-displayed, via fusion to Aga1p, to recruit base coil-fused C-terminal fragment ("EX", amino acids 201−250 of APEX2). In the positive selection for high sAPEX activity, base coil-EX-GFP was incubated with the AP-3 yeast library for 10 min, and then the reconstituted peroxidase activity was detected by treating the cell mixture with biotin-phenol (BP) and H 2 O 2 . Cells with high peroxidase activity label themselves with biotin to a high extent, 16 enabling their enrichment via FACS after streptavidin−phycoerythryin (PE) staining. In the negative selection to deplete the sAPEX library of AP-3 fragments with excessively high affinity for EX, we incubated the AP-3 yeast library with EX-GFP protein lacking base coil for increasingly long time periods (see Figure S7A ), then performed BP labeling. Cells with low streptavidin−PE signal were retained via FACS. Myc staining on the x axis provides a readout of AP expression level. Note that the fluorescence from GFP was not measured during FACS; GFP was included to increase the solubility of EX. Hypothetical data are shown to illustrate the strategy for gate selection. (B) Summary of improvement of sAPEX activity and PPI dependence throughout generations of selections in yeast. Full-length APEX2 fusion to Aga2p was used as a benchmark for desired activity range. Yeast were prepared as in panel A, with the indicated N-terminal fragment of sAPEX expressed on the yeast surface as a fusion to Aga2p. Purified C-terminal fragment (EX), either with or without acid coil, was added to the cells for 10 min or 7 h, respectively. Next, BP labeling, streptavidin−PE staining, and FACS were performed as in panel A. AP-1, AP-2, and AP-3 are the first-, second-, and third-generation N-terminal fragment clones, whose mutations are shown in panel C. The percentage of myc-positive cells in the top right quadrant (Q2) is indicated in the top right corner of each FACS plot. Data are shown for one out of two biological replicates. (C) Summary of split APEX protein engineering. The name of the best N-terminal fragment clone to emerge from generation 1 selection is "AP-1″, and so on, as indicated. The be the excess pool of catalytically active APEX2-RBP fusion protein that is not docked to the tagged RNA and can therefore produce off-target labeling that masks the specific signal.
A general solution to both of these, and related, problems could be a split form of APEX2, in which two inactive fragments of APEX2 reconstitute to give an active peroxidase only when they are physically co-localized ( Figure 1A ). One could apply this intersectional approach to restrict APEX2 activity specifically to sites of interest (such as mito-ER contacts or specific RNA binding sites), thus eliminating the background labeling from off-target peroxidase.
Although split protein reporters have been developed from green fluorescent protein (GFP), 36, 37 54 splitting APEX2 presents new challenges. First, APEX2 requires a heme cofactor for its activity, and many cut sites would divide the heme-binding pocket across the two fragments ( Figures 1B  and S1 ). Second, for split APEX2 to be useful for a broad range of applications, the inactive fragments should have relatively low affinity for one another, such that reconstitution only occurs when the fragments are driven together by a molecular interaction. Not many known split proteins have low-affinity fragments, 44 and it is challenging to engineer such a property in conjunction with high activity upon reconstitution.
To address the need for an interaction-dependent proximity labeling tool, we describe here the development of an evolved split APEX2 (sAPEX) system. Using a novel yeast-displaybased directed evolution approach that incorporates positive and negative selection steps, we have attempted to minimize interaction-independent association of the peptide fragments while maintaining high peroxidase activity upon reconstitution. Our resulting sAPEX fragment pair diverges substantially from its parental sequence and shows interaction-dependent reconstitution in multiple contexts in living mammalian cells. Our sAPEX tool adds to the proximity labeling toolkit and, in the future, should extend the utility of APEX-based approaches to new areas of biology at higher spatiotemporal resolution.
■ RESULTS
Structure-Guided Screening of Potential APEX2 Cut Sites. We first sought to identify promising cut sites in the APEX2 enzyme using a chemically inducible protein association system as a test platform. We selected 24 potential cut sites within solvent-exposed loops and turns between secondary structural elements (α helices and β sheets) based on the crystal structure of wild-type ascorbate peroxidase 55 ( Figures 1B and S1 ). Cut sites were also selected to avoid the creation of hydrophobic termini that might destabilize the fragments. All fragments were expected to lack a complete heme-binding pocket, with the exception of the large fragments produced from cut sites 7/8 and 29/30. We cloned each of the 24 fragment pairs as fusions to FKBP and FRB, whose interaction can be induced with the small molecule rapamycin ( Figure 1C) . We introduced the fragment pairs into HEK 293T mammalian cells using transient transfection and evaluated peroxidase activity in the presence or absence of rapamycin. Catalytic activity was detected using an established assay based on the membrane-permeable fluorogenic probe Amplex UltraRed, which is colorless but is converted into the red fluorophore resorufin upon peroxidase-catalyzed oxidization. 56, 57 Of the 24 fragment pairs tested, 7 produced significant resorufin product, indicative of reconstituted activity ( Figure  1D ). For all cut sites except 7/8, much stronger activity was detected in the presence of rapamycin compared to when rapamycin was omitted, indicating that reconstitution was dependent on a protein−protein interaction. In the case of cut site 7/8, resorufin fluorescence was observed not only when rapamycin was omitted but also when the large C-terminal fragment (amino acids 8−250) was expressed on its own ( Figure S2 ), making this cut site unsuitable for our purposes. Cut sites within the heme binding cavity (130/131, 135/136, 146/147, 170/171, 173/174, and 181/182) produced fragments that completely failed to reconstitute activity (see Figures 1B and S1 for recolored full length APEX2; PDB: 1OAG).
To more finely map the optimal cut sites, we performed a second round of screens, evaluating cut sites 1−3 residues away from promising sites identified in our initial screen ( Figures 1E and S2 ). Some cut sites, such as 123/124, were not pursued because, while they may have shown comparable activity to promising sites such as 89/90, they demonstrated poorer expression, which led to less consistent biotinylation signals. For cut site 123/124, it is possible this lack of stability may be due to a C-terminal proline formed with the split. Similarly, while cut site 198/199 showed similar activity to cut site 200/201, cut site 200/201 is more distal from secondary structures, i.e., in the middle of a flexible loop region, which we hypothesized could reduce structural perturbations. We ultimately identified three optimal cut sites (51/52, 89/90, and 200/201), all of which fell in solvent-exposed loops far (>15 Å away) from the APEX2 active site and heme-binding pocket. For each cut site pair, controls in which either the Nor C-terminal fragments were expressed alone lacked any detectable peroxidase activity ( Figure S2 ).
To assess the efficacy of our split APEX2 fragment pairs for applications in EM and proximity biotinylation, we evaluated their activity using the small molecule substrates diaminobenzidine (DAB) 1, 16 and biotin phenol (BP), 2−4 respectively. Despite positive results in the highly sensitive Amplex UltraRed assay ( Figure 1D ,E), all three split APEX2 pairs produced far weaker DAB and BP staining than full-length APEX2 ( Figure S3 ; data not shown). For example, HEK 293T cells expressing full-length APEX2 exhibited very strong DAB staining after 15 min, while DAB staining by cut site 200/201 constructs was hardly detectable under identical conditions ( Figure S3A ). We found that the recently reported Yeast-Display-Based Platform for Split APEX2 Evolution. The low activity of split APEX2 could be caused by a variety of factors, including poor stability, misfolding, aggregation of the fragments, or distorted geometry of the reconstituted active site and heme binding pocket, which could lead to low catalytic efficiency and poor heme recruitment. It is difficult to assess each of these potential problems, and even more difficult to fix them in a rational manner. Hence, we turned to directed evolution, which we and many others have harnessed to improve or alter the properties of enzymes. 16,38,59−63 We selected yeast-display-based directed evolution ( Figure 2 ) because, in contrast to other strategies such as high-throughput screening and phage display, yeast display allows the processing of large mutant libraries ( >10 7 ) with large dynamic range: enrichment based on fluorescenceactivated cell sorting (FACS) enables the separation of highly active catalysts from moderately active ones, not just from inactive catalysts. 16 to allow peroxidasecatalyzed polymerization of DAB. Four separate fields of view are shown per condition. Scale bar: 20 μm. Two biological replicates were performed. (C) Same assay as in panel B except that FKBP-AP was introduced by lentiviral infection, and live BP labeling was used to detect peroxidase activity. Infected HEK 293T cells were treated with BP in the presence of H 2 O 2 for 1 min and then fixed and stained with neutravidinAlexaFluor647 to visualize peroxidase-catalyzed promiscuous biotinylation. 2 Scale bar: 20 μm. A total of four biological replicates were performed. Additional fields of view are shown in Figure S8 . Again, the comparison to full-length APEX is with stable HEK 293T cells. (D) Same assay as in panel C but with streptavidin blot readout. Anti-V5 and anti-HA blots detect expression of N-terminal and C-terminal fragments, respectively. A pair of biological replicates was performed.
Our initial yeast display selection scheme exploited the yeast mating proteins Aga1p and Aga2p, which are displayed on the yeast cell surface and are joined by two disulfide bridges (Figures 2A and S4A) . A library of yeast cells was generated, with each cell displaying on its surface a different mutant of the N-terminal split APEX2 fragment via fusion to the mating protein Aga2p. All cells concomitantly displayed the same Cterminal split APEX2 fragment as a fusion to Aga1p. The fragments were allowed to reconstitute for ∼20 h after the induction of protein expression. To read out the resulting peroxidase activity, APEX2-mediated biotinylation was initiated with biotin-phenol and H 2 O 2 , using standard conditions. 16 Yeast cells that display active reconstituted peroxidase under these conditions should promiscuously biotinylate proteins on their cell surface, which can be quantified using FACS (Figures 2A and S4A) .
To establish this selection platform, we first created yeast Aga1p/Aga2p fusion constructs using the three promising split APEX2 pairs identified in the above screen. Because the 51/52 and 89/90 fragment pairs expressed poorly in yeast and gave no detectable activity on the yeast surface (data not shown), we proceeded with the directed evolution of the 200/201 fragment pair. The C-terminal fragment (amino acids 201−250 of APEX2, henceforth called "EX") was held constant while the N-terminal fragment (amino acids 1−200 of APEX2, called "AP-0") was mutagenized using error prone PCR. Sequencing showed that our AP-0 library contained an average of 1.4 amino acid mutations per clone (see the Methods section).
We performed four rounds of selection and observed that the activity of the yeast pool (measured by FACS) progressively increased ( Figure S4B ). We isolated 12 individual clones, characterized their activity on yeast using FACS and in the mammalian cytosol using microscopy, and combined mutations that appeared to be beneficial. The result was "AP-1", which contains 3 mutations relative to the original APEX2 ( Figure 2C ). In a side-by-side comparison to the original split APEX2 fragment pair (AP-0 plus EX) in HEK 293T cells, AP-1 shows noticeably improved activity in both DAB and BP labeling assays ( Figure 3A−C) .
To further improve the reconstituted activity of split APEX2, we performed another set of yeast selections in which the Cterminal EX fragment was not co-displayed on Aga1p but instead supplied as a purified, soluble protein ( Figure S5A ). This configuration allowed us to precisely control the concentration of EX added and the time of incubation and to select for mutations that improved AP-1 expression and stability in the absence of EX co-translation. However, because the fragments only encountered each other on the yeast surface, where endogenous heme is not available, it was necessary to supply exogenous heme to the cells both during and prior to EX fragment addition. A total of four rounds of selection using this scheme produced the clone "AP-2", which has three mutations beyond those in AP-1 ( Figure 2C) .
In a third-generation effort, to drive the fragments together using a protein−protein interaction (PPI), we again added EX as a soluble protein, but we used an artificially designed coiledcoil system, ACID-p1 and BASE-p1, 64 to recruit EX to the proximity of the N-terminal fragment (AP-2) ( Figure S6 ). This configuration mimics the split APEX2 reconstitution that would occur in our target biological applications. A total of four rounds of selection with gradual reduction of EX concentration and incubation time produced clone "AP-3", which incorporates one additional mutation relative to "AP-2" and has noticeably higher activity than preceding clones in both DAB and BP labeling assays in HEK 293T cells ( Figures  2C and 3) .
FACS-Based Negative Selections for Reduced Intrinsic Fragment Affinity. An ideal split APEX2 fragment pair would have high catalytic activity when reconstituted but low intrinsic binding affinity between the fragments, such that reconstitution occurs only when the fragments are driven together by a PPI ( Figure 1A ). The clone AP-3, obtained after three generations of directed evolution, has much greater reconstituted activity with EX than does the original template (AP-0), but this activity was not dependent on PPI-induced co-proximation. Using FRB and FKBP fusion proteins in HEK 293T cells, for example, we observed considerable DAB and BP signal even in the absence of rapamycin ( Figure 3) .
Hence, we devised a new yeast-display-selection scheme that alternates between positive and negative selection rounds ( Figure 2A ). For the positive selection, we supplied the purified EX protein fused to the BASE-p1 helix that facilitates recruitment to Aga1p-ACID-p1. We performed BP labeling followed by streptavidin−phycoerythrin and antimyc antibody staining. FACS was used to enrich cells with high SA-to-myc intensity ratios, as above. For the negative selection, we incubated the yeast with EX protein lacking BASE-p1 coil for extended periods of time (3 to 25 h). AP-3 mutants that reconstituted with EX under these PPI-independent conditions were eliminated by FACS.
Starting with a library of 4.8 × 10 7 AP-3 variants, we performed 2 rounds of positive selection and 6 rounds of negative selection ( Figure S7A ). By round 8, the yeast population was substantially depleted of cells that could reconstitute APEX2 activity upon addition of EX lacking the BASE-p1 coil ( Figure S7B ). We isolated 4 unique clones, characterized them by FACS, combined beneficial mutations, and retested in the mammalian cytosol. These experiments resulted in AP, the final split APEX2 (sAPEX) N-terminal fragment, which contains 9 mutations compared to the original APEX2 sequence ( Figure 2C ). Mapping the positions of these 9 mutations (G50R, K61R, and I165L from generation 1; R24G, H62Y, and N72S from generation 2; K22R from generation 3; and P125L and I185 V from generation 4) onto the structure of wild-type ascorbate peroxidase, we observe that all lie in solvent-exposed regions, and none are at the interface between AP and EX ( Figure 2D ). Interestingly, half of the mutations are adjacent to cut sites we screened in Figure  1D ,E, and many of the mutations were clustered in specific regions of the protein structure ( Figure 2D ).
Characterization of Enriched Clones. Having completed 20 rounds of selection using three different yeast display configurations, we characterized key clones side-by-side. First, we prepared yeast displaying AP-0 (the starting template), AP (N-terminal fragment of final sAPEX), full-length APEX2, and AP-1 to AP-3 mutants, as fusions to Aga2p. Aga1p on these cells contained the ACID-p1 coil. We then supplied EX protein, either fused to ( Figure 2A , top row) or lacking (bottom row) the BASE-p1 coil for proximity-dependent reconstitution. Figure 2B shows that the streptavidin− phycoerythrin (PE) staining (indicating reconstituted peroxidase activity) progressively increases from the template AP-0 to the finalized AP. However, the signal in the bottom row, reflecting proximity-independent reconstitution with EX (lacking the BASE-p1 coil), also increases, which is undesirable. After the implementation of negative selections in generation 4, however, the untagged EX signal decreases for the AP clone. The EX plus BASE-p1 coil signal remains high for AP, although it is not quite as high as that seen for AP-3. These observations on yeast indicate that the selections worked as desired and that our final clone AP combines the features of high reconstitution activity with low proximityindependent reconstitution.
We next tested whether these trends would hold in the mammalian cell cytosol. This environment is different from the yeast cell surface: it is 37°C instead of 30°C and reducing rather than oxidizing. We also wished to test the sAPEX clones as soluble proteins rather than membrane-anchored constructs with restricted geometry. Hence, we expressed the N-and Cterminal fragments from each stage of directed evolution as fusions to FKBP and FRB, respectively ( Figure 3A ). We first compared peroxidase activity with or without rapamycin using our DAB assay (relevant for EM applications), 1, 16 which is much less sensitive than both Amplex UltraRed and BP assays, enabling us to more rigorously compare the activity of our sAPEX fragment pairs ( Figure 3B ). The original sAPEX template, AP-0, gave barely detectable DAB staining, while AP-1 was dramatically improved, and AP-3 gave the strongest staining. However, as observed in yeast, AP-3 also gave significant signal in the absence of rapamycin, indicating high PPI-independent reconstitution. In contrast, the final AP plus EX clones displayed high DAB staining in the presence of rapamycin but nearly undetectable staining in the majority of cells in the absence of rapamycin.
Analogous experiments using the BP assay (relevant for spatial proteomics 2, 3 and transcriptomics) 65 showed a similar trend ( Figures 3C and S8 ). While AP-3 showed high activity following rapamycin treatment, it also revealed background labeling in the −rapamycin condition. In contrast, the final sAPEX pair, AP plus EX, displayed rapamycin-stimulated activity comparable to that of AP-3 but reduced activity in the majority of cells in the absence of rapamycin. We also characterized BP labeling in HEK 293T cells ( Figure 3D ) and COS7 cells ( Figure S9B ) by lysing the cells and blotting the cell lysate with streptavidin−HRP. The same trends were apparent, and we were furthermore able to estimate that reconstituted sAPEX has ∼33% of the activity of full-length APEX2 ( Figure S9C ).
sAPEX Reconstitution on a Target RNA. As APEXcatalyzed proximity biotinylation has demonstrated utility for mapping protein interactomes, 7−9 there has been interest in using APEX2 to also map the interactomes of target nucleic acids−RNAs and individual genomic loci. In theory, this could be accomplished by fusing full-length APEX2 to programmable RNA-or DNA-binding proteins (such as CRISPR-Cas13d or Cas9, respectively) 66−68 that specifically target the RNA or genomic locus under investigation. Alternatively, target RNAs or DNA loci could themselves be tagged with motifs that specifically bind APEX2 fusion proteins. 69 However, each of these approaches would be plagued by pools of excess catalytically active APEX2 that is unbound to the target of interest. This is exemplified by recent studies that used dCas9 to recruit APEX2 to specific genomic loci 67, 68 and a separate study that used the bacteriophage MS2 RNA coat protein (MCP) to recruit promiscuous biotin ligase variants to RNAs appended with the cognate MS2 RNA motif. 69 An analogous APEX2-MCP fusion system would most likely also suffer from background biotinylation that overwhelms the specific signal from RNA-bound APEX-MCP.
We reasoned that our sAPEX system could potentially be used to alleviate this problem by fusing the evolved AP and EX fragments to orthogonal RNA-binding proteins and selectively reconstituting APEX2 peroxidase activity on target RNAs that are appended with both of the cognate protein-binding RNA motifs ( Figure 4A,B) . As proof of principle, we applied this strategy to TERC, the non-coding RNA component of the telomerase ribonucleoprotein (RNP), which synthesizes the ends of chromosomes in many clades of eukaryotes. 70 In addition to providing the template for telomere synthesis, the TERC RNA is also thought to serve as a structural "scaffold" onto which the other holoenzyme components assemble. 71 Critically, proper biogenesis of functional telomerase RNPs can be recapitulated when TERC RNA is transiently expressed from a plasmid, even if the RNA is appended with exogenous sequences at its 5′ end. 72 We therefore designed a series of variants in which the TERC 5′ terminus is appended by cassettes of motifs recognized by RNA-binding proteins. For this purpose, we chose to express AP and EX as fusions to the MS2 and PP7 bacteriophage nucleocapsid proteins (respectively termed MCP and PCP), which recognize disparate RNA motifs with exquisitely high affinity and specificity (cognate Constructs used for targeting AP and EX fragments of sAPEX to the outer mitochondrial membrane (OMM) and ER membrane (ERM), respectively. (E) Schematic overview of sAPEX applied at mito-ER contacts. Inactive fragments (gray) fused to FKBP and FRB can reconstitute to give active peroxidase (green) when driven together by an inducible protein−protein interaction (PPI) with the addition of rapamycin (yellow diamond). (F) sAPEX reconstitution in COS7 mammalian cells. COS7 cells stably expressing EX-FRB-ERM from panel D were infected with lentivirus containing OMM-FKBP-AP. A total of 46 h later, cells were incubated with heme for 90 min prior to incubation with BP in heme-free media in which rapamycin was added or omitted, as indicated. BP labeling was initiated by the addition of H 2 O 2 , and after 1 min, cells were fixed and stained with neutravidin-AlexaFluor647 to visualize reconstituted sAPEX activity. HA and V5 staining show the localizations of total EX and total AP, respectively. The top row is a negative control with rapamycin omitted. Scale bar: 10 μm. Additional fields of view are shown in Figure  S10 . This experiment has four biological replicates. (G) Reconstituted sAPEX has reactivity toward DAB in COS7 mammalian cells. COS7 cells stably expressing EX-FRB-ERM from panel D were infected with lentivirus containing OMM-FKBP-AP. After 48 h, cells were incubated with heme for 90 min prior to the rapamycin incubation in heme-free media for 30 min. Cells were then fixed, and DAB polymerization was performed for 15 min. In the bright-field images, dark regions indicate peroxidase activity. Scale bar: 10 μm. Representative fields of view from three biological replicates are shown. (H) sAPEX can be used as a genetically encoded reporter for EM. Samples from panel G with 30 min of rapamycin incubation were analyzed by EM. Dark staining from osmium tetroxide recruitment to sAPEX-generated DAB polymer is observed exclusively at sites where ER is in proximity to mitochondria (M). Scale bars: 250 nm. An additional field of view is shown in Figure S14A . This experiment represents a single biological replicate.
RNA K D of ∼1 nM and non-cognate RNA K D of ∼1 mM) 35,73−75 ( Figure 4A −C). Anticipating that sAPEX reconstitution might be sensitive to the specific geometry with which the AP and EX fragments are co-proximated, we designed a series of TERC variants that positioned MS2 and PP7 stem loops in different orientations ( Figure S10 ).
The expression of MCP−AP and PCP−EX resulted in biotinylation that was dependent on the presence of a TERC RNA bearing both of the cognate MS2 and PP7 motifs ( Figures 4C and S11) . Critically, we observed no such biotinylation when individual MS2 and PP7 hairpins were localized on separate TERC RNA constructs. Moreover, the labeling pattern appeared punctate, as would be predicted from localizing peroxidase activity to the discrete subnuclear foci characteristic of interphase telomerase. 76 Consistent with these results, streptavidin blotting of whole cell lysates also shows that expression of MCP−AP and PCP−EX results in biotinylation activity only when they are co-expressed with TERC RNA bearing both MS2 and PP7 hairpins ( Figure S12 ). Together, our data suggest that sAPEX activity can be specifically reconstituted on a target RNA by nucleating protein fragment assembly on a structured RNA cassette.
sAPEX Reconstitution at Mitochondria−ER Contacts. In mammalian cells, an estimated 5−20% of the mitochondrial (mito) outer membrane makes intimate contact (<70 nm gap) with the membrane of the endoplasmic reticulum (ER). 19 These mito-ER contacts are thought to be important for a variety of functions and signaling processes, from mitochondrial fission to lipid synthesis. 18−25 Recent work has identified proteins that reside at mito-ER contacts and may play a role in tethering the membranes together. 4 ,29 A major goal of this field is to comprehensively characterize the molecular composition of these contact sites to better understand how they mediate important cellular processes. To pave the way for such future efforts, we tested whether sAPEX activity could be reconstituted at mito-ER contact sites.
Mito-ER contacts are delicate and easily perturbed structures. The overexpression of various proteins, such as SYNJ2BP or even green fluorescent protein, can lead to the dramatic distortion of one or both organellar membranes. 4, 77 Because our optimized sAPEX fragment pair, AP plus EX, does not exhibit PPI-independent reconstitution, we reasoned that it might be capable of reconstitution at mito-ER contacts without major perturbation of organellar structure. Figures 4D−F and S13 show AP-FKBP targeted to the OMM and EX-FRB targeted to the ERM in COS7 cells, which are flat and thin, facilitating the visualization of mitochondria and ER structures. We observed BP/streptavidin staining in cells treated with rapamycin for 30 min. Consistent with the PPI dependence of sAPEX reconstitution, no BP labeling was observed when rapamycin was omitted. We also stained the COS7 cells for mitochondrial and ER markers and observed minimal disruption of organellar morphology, both before and after rapamycin addition ( Figure S13B,C) .
To examine sAPEX at mito-ER contacts at higher resolution, we took advantage of APEX's ability to generate contrast for electron microscopy (EM). 1, 16 We fixed COS7 cells prepared as above, and incubated them with DAB and H 2 O 2 to allow reconstituted sAPEX to catalyze the oxidative polymerization and local deposition of DAB.
1 Bright-field imaging showed dark threads corresponding to stained mitochondria in the 30 min rapamycin-treated samples but not in the untreated samples ( Figure 4G ). We next stained the rapamycin-treated samples with OsO 4 to deposit electron-dense osmium on the DAB polymer and then embedded and sectioned the samples for EM. EM imaging revealed a dark stain, corresponding to regions of reconstituted sAPEX activity, exclusively at contact sites between mitochondria and ER ( Figures 4H and S14A) . A pair of zoomed-in views show that DAB staining filled the ∼25 nm gap between the OMM and ERM in samples that were treated with rapamycin but was absent from isolated ER and mitochondrial membranes. Furthermore, DAB staining was absent from samples that were not treated with rapamycin ( Figure S14B ).
■ DISCUSSION
Using a combination of rational design and yeast-display directed evolution, we have engineered a low-affinity sAPEX protein complementation assay (PCA) with robust activity upon reconstitution driven by co-proximation. After three generations of evolution, our intermediate AP-3 fragment was highly active but gave PPI-independent background reconstitution. To overcome this, our final directed evolution strategy implemented a negative selection that eliminated yeast clones with high fragment affinity. The final engineered sAPEX fragments, AP and EX, possess a total of nine mutations relative to the starting APEX2 template, clustered at solvent exposed regions, that collectively improve the PPI dependence of this system while maintaining high catalytic activity of the reconstituted form. In principle, our yeast-display platform could be extended to engineer other PCA systems. Highaffinity fragment pairs such as those of split GFP result in spontaneous and irreversible reconstitution; 78 similarly, split HRP irreversibly reconstitutes in the ER without a PPI. 38 Split YFP utilizes fragments that reconstitute in a more PPIdependent manner, 79, 80 but it still suffers from background fluorescence, especially at high expression levels, and from irreversible YFP self-assembly. 81, 82 Given the purportedly broad array of novel RNAs and RNAmediated processes that have eluded mechanistic dissection, 83 and the growing number of diseases now thought to be mediated by aberrant RNA−protein interactions, 84, 85 there is a great need for methods that enable the identification of interaction partners of specific RNAs. Conventional approaches address this problem by capturing and enriching a target RNA along with its bound interaction partners either using affinity-tagged antisense oligonucleotides that isolate endogenous transcripts 86−89 or by affinity-tagging the transcript of interest itself. 90, 91 However, these approaches are often confounded by the abundance of the target transcript, the unpredictable performance of RNA-based affinity tags, 92 and nonspecific RNA-protein interactions formed during lysis and enrichments. 93 Using RNA scaffolding motifs to target the reconstitution of sAPEX eliminates high off-target background signal from protein over-expression. sAPEX demonstrates promise for BP labeling around specific RNAs, which indicates potential future applications to elucidate interactomes and interaction partners of an RNA of interest. Moreover, because the RNA domain we used to recruit AP and EX was designed to be functionally independent of the RNA to which it is appended, it should in theory be adaptable to other RNA targets. 94 A downside to this approach, however, is the need to express the transgenic, tagged RNAs that may not properly fold, localize, or function. As an alternative strategy, one might use RNA-targeting CRISPR-Cas systems to recruit AP and EX to endogenously expressed RNAs. 66 This approach may require substantial optimization to juxtapose the AP and EX fragments in the proper orientation and may be influenced by the sequence, structure, or proteome of the targeted RNA.
The ability to reconstitute APEX2 activity at an organellar junction represents a promising step toward gaining greater understanding of subcellular locales that were previously intractable to genetic targeting. We found that the reconstitution of sAPEX at mito-ER contact sites was PPIdependent despite multiple days of cotranslation of the sAPEX fragments.
Unlike most other PCAs, sAPEX possesses the versatile ability to react with many different substrates, enabling its use for a wide array of applications. Because sAPEX activity can be reconstituted in highly specific subcellular regions that are inaccessible by single-gene constructs, it expands the toolkit of proximity labeling technologies.
■ METHODS
Cloning. See Supplementary Table 1 for a list of genetic constructs used in this study, with annotated epitope tags, promoters, resistance genes, vector name, linkers sequences, etc. For cloning, PCR fragments were amplified using Q5 polymerase (New England BioLabs, NEB) or PfuUltra II Fusion HS DNA polymerase (Agilent Technologies). The vectors were double-digested and ligated to gelpurified PCR products by T4 ligation or Gibson assembly. Ligated plasmid products were introduced by heat-shock transformation into competent XL1-Blue bacteria. The APEX2 gene used for initial cut site screening was amplified from vimentin-APEX2 with codons optimized for mammalian expression. Mutants of AP were generated either using QuikChange mutagenesis (Stratagene) or isolated from individual yeast clones and transferred to mammalian expression vectors using standard cloning techniques.
To generate tagged RNA expression constructs (Figures 4A−C and S10), the TERC RNA and the hTR500 3′ processing block 72 were amplified as a single product from HEK 293T genomic DNA, via nested PCR. DNA fragments encoding the structured RNA cassettes ( Figure S10 ) were synthesized by primer extension from overlapping oligonucleotides or as gBlocks (Integrated DNA Technologies, Inc.). TERC and cassette inserts were ligated into the RNA transient expression vector pCMV−SV40pA, 95 from which the existing polyadenylation site had been removed via standard two-or threepiece restriction-digest cloning.
MCP-and PCP-tagged constructs (Figures 4A−C and S11) were generated as follows. Genes encoding single protomers of the phage coat proteins were amplified from plasmids pHA_MS2-VP64 and pHA_PP7-VP64. 95 Upstream fragments encoding the Kozak sequence, nuclear localization sequence (NLS), and V5 (MCP) or flag (PCP) tags were synthesized by primer extension from overlapping oligos (Integrated DNA Technologies, Inc.). Full-length APEX2 was amplified from mito-V5-APEX2. 2 The three-fragment pools (upstream fragments, phage coat protein, and APEX2) were restriction digested and then ligated using T4 DNA ligase (New England Biolabs). This ligation mixture was then used as template for a subsequent round of PCR to isolate the full chimeric insert. These full-length PCR products were then inserted into pCMV−SV40pA by standard restriction-digest cloning. For cloning MCP-AP and PCP-EX, similar methods were employed.
Mammalian Cell Culture and Transfection. HEK 293T and COS7 cells from ATCC (passages of <20) were cultured as monolayers in complete growth media consisting of 50% Dulbecco's modified Eagle medium (DMEM, Gibco) and 50% minimum essential medium (MEM, Gibco) supplemented with 10% w/v fetal bovine serum (FBS, Sigma), 50 units per milliliter penicillin, and 50 μg/mL streptomycin at 37°C under 5% CO 2 . For streptavidin blotting experiments, cells were grown on polystyrene 6-well plates (Corning). For confocal imaging experiments, cells were grown on 7 mm × 7 mm glass coverslips in 48-well plates (Corning). To improve the adherence of HEK 293T cells, the glass cover slips were pretreated with 50 μg/mL fibronectin (Millipore) in Dulbecco's phosphatebuffered saline (DPBS), at pH 7.4, for 20 min at 37°C, followed by two washes with growth media prior to cell plating. Cells were transfected at 70−85% confluence using Lipofectamine 2000 (Life Technologies), with 1.0 μL of lipofectamine and 200 ng of each plasmid per 300 000 cells in serum-free media for 3−4 h, after which transfection media was replaced with fresh complete growth media. Cells were labeled, fixed, or both 18−24 h after transfection. The cell line was not authenticated or tested for mycoplasma.
Lentivirus Generation and Mammalian Cell Infection. To generate viruses, HEK 293T cells plated in a T25 flask (Corning) were transfected at ∼75−90% confluency with 5 mL of serum-free MEM containing the lentiviral plasmid encoding the gene of interest (2500 ng), the lentiviral packaging plasmids dR8.91 (2250 ng) and pVSV-G (250 ng), and 30 μL of 1 mg mL −1 polyethylenimine "Max" (Polysciences) pH 7.1 for 3−4 h, followed by media change with complete MEM. A total of 48 h after transfection, the cell medium containing lentivirus was harvested, filtered through a 0.45 μm filter, and added to other fresh cell cultures to induce expression of the gene of interest. Typically, for both HEK 293T and COS7 cultures plated in wells of a 48-well plate (0.95 square centimeters per well), cells were plated approximately 12−16 h prior to lentiviral transduction in 1:1 DMEM/MEM complete growth media. HEK 293T and COS7 cells, at ∼70% and ∼85% confluency, respectively, were then infected by exchanging the medium with 150−200 μL of complete MEM and 50−100 μL of viral medium. Cells were then incubated for 48 h at 37°C with 5% CO 2 prior to heme incubation, labeling, and imaging. In the experiment shown in Figure 3D , the N-terminal AP fragment of sAPEX was transiently expressed via lentiviral infection, and the full-length APEX2 was stably expressed. This procedure resulted in a reduced number of comparable HEK 293T cells that would express both fragments compared to cells expressing full-length APEX2. Therefore, when comparing our final sAPEX to full-length APEX2 in the cytosol of COS7 cells, both the N-terminal AP fragment of sAPEX and full-length APEX2 were lentivirally introduced with similar infection efficiencies (C-terminal EX fragment of sAPEX was stably expressed in cells infected with FKBP-AP lentivirus; Figure S9 ).
Generation of Stable Cell Lines. To generate stable cell lines, constructs of interest were cloned into the lentiviral vector pLX304 to make virus, as described above. Low-passage HEK 293T cells (<20 passages) plated in 6-well plates (Corning) were infected with 800− 1000 μL of infectious medium for APEX2-NES, FRB-EX, or MCP-AP ( Figures 3B,C , 4A−C, S3, and S9A). After 2 days at 37°C and 5% CO 2 , each well was trypsinized and replated into two T25 flasks in full growth media containing 8 mg mL −1 blasticidin S HCl (Calbiochem, CAS no. 3513-03-9). Media was changed to fresh 8 mg mL −1 blasticidin S HCl media every 24 h. Cells were trypsinized and replated before reaching full confluency within the first 7 days. After 7−10 days of selection, surviving cells were used for experiments. To make cells stocks for long-term storage at −80°C, cells from a ∼ 90% confluent T75 flask were harvested, pelleted, resuspended in 5 mL of complete media with 5% DMSO, and cooled to −80°C overnight using a Mr. Frosty freezing container (Thermo Scientific). COS7 cells stably expressing EX-FRB-ERM from Figures 3D, Figure 4D −H, S9B, and S13 were prepared similarly, with a selection in media containing 10 mg mL −1 blasticidin S HCl. Heme Supplementation. Where indicated in both yeast and mammalian culture, heme was supplemented by dilution from a thawed 300 μM heme stock solution, which was prepared by dissolving hemin-Cl (Sigma) in 10 mM NaOH with sonication for 3 min, aliquoting, flash freezing in liquid N 2 , and storing at −80°C. Heme stocks were used within 1 h after thawing and never reused. Heme stock was diluted to 5 μM and 6 μM in complete growth media and added to HEK 293T and COS7 cells, respectively, for 90 min prior to BP incubation (without heme) or DAB labeling. For yeast heme supplementation in generations 2−4, washed yeast cells were pelleted at 7000 × g for 1 min and resuspended to a concentration of 1.5 × 10 7 yeast cells/mL in DPBS-B with 0.1% BSA at the designated heme concentrations ( Figures S3B, S4B , and S5A) immediately prior to EX incubation. Amplex UltraRed Assay. HEK 293T cells plated on glass cover slips were transfected as described above with 200 ng of each plasmid encoding a peroxidase fragment and 100 ng of plasmid encoding CFP-NLS in tandem as a transfection marker for 3 h. Transfection media was then replaced with complete medium with or without 400 nM rapamycin (Calbiochem), which was delivered by 1000-fold dilution of a 400 μM stock in DMSO maintained at −20°C for months and thawed as needed. After 18−22 h, cells were moved to ice, washed 3 times with DPBS, and treated with a solution of 50 μM Amplex UltraRed (Life Technologies) with 0.02% (6.7 mM) H 2 O 2 in DPBS according to previously published protocols. 1, 16, 38 Cells were labeled for 25 min on ice. The reaction was quenched by removal of the substrate solution by aspiration, and cells were subsequently washed three times with DPBS, fixed with 4.0% formaldehyde in DPBS (v/v) on ice for 30 min, and washed 2 more times with DPBS before being imaged by confocal microscopy. Details of the assay are shown in Figures 1D,E and S2 .
Biotin-Phenol Labeling. Genes were introduced into HEK 293T or COS7 cells through either transient transfection with Lipofectamine 2000 or lentiviral infection. After 18−24 h (transfection) or 48 h (lentivirus), BP labeling was initiated by changing the medium to 200 μL of fresh growth medium containing 500 μM BP that was sonicated for at least 5 min to ensure BP was fully dissolved. Cells were incubated at 37°C under 5% CO 2 for 30 min according to previously published protocols. To initiate labeling, 2 μL of 100 mM H 2 O 2 was added to each well, yielding a final concentration of 1 mM H 2 O 2 , and the plate was immediately gently agitated. To quench the reaction after 1 min, the BP solution was aspirated, and cells were immediately fixed with 4% formaldehyde in PBS (v/v) with 5 mM Trolox at RT for 5 min before continuing fixation on ice for an additional 25 min. Cells were then washed with chilled DPBS three times and permeabilized with prechilled methanol at −20°C for 10 min. Cells were washed again 3 times with DPBS and blocked with 3% BSA in DPBS for 1 h to overnight with rocking at 4°C. To detect the expression of sAPEX fusions, cells were incubated with primary antibodies mouse anti-V5 (Life Technologies, catalog no. R96025, 1:1500 dilution) and rabbit anti-HA (Cell Signaling Technology, catalog no. 3724, 1:1000 dilution) in 1% BSA in DPBS for 1 h to overnight at 4°C followed by 4 washes of 5 min apiece with chilled DPBS. Cells were then incubated with a 1% BSA in DPBS (v/v) solution containing secondary Alexa Fluor 488-goat anti-rabbit IgG (Life Technologies, catalog no. A-11001, 1:1000 dilution), Alexa Fluor 568-goat anti-mouse IgG (Life Technologies, catalog no. A-11004, 1:1000 dilution), and homemade streptavidin−Alexa Fluor 647 (1:1000) for 25−45 min at 4°C with rocking. Cells were then washed 4 times for 5 min each with chilled DPBS and imaged by confocal microscopy. Details are shown in Figures 3C ; 4C,F; S3B; S3C; S8; S9B; S11; and S13.
Western Blotting. For streptavidin blotting, cells were grown on polystyrene 6-well plates (Corning) and labeled under the same conditions described above (see the Biotin−Phenol Labeling"). After 1 min of labeling, the cells were washed 3 times with RT quencher solution (10 mM sodium azide, 10 mM sodium ascorbate, and 5 mM Trolox in DPBS) and then scraped and pelleted by centrifugation at 1400 rpm for 3 min. The cell pellet was then lysed by gentle resuspension into peroxidase quencher-containing RIPA lysis buffer including 50 mM Tris, 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 1% Triton X-100, 1× protease cocktail (Sigma-Aldrich, catalog no. P8849), 1 mM PMSF (phenylmethylsulfonyl fluoride), 10 mM sodium azide, 10 mM sodium ascorbate, and 5 mM Trolox. After 2 min on ice, the lysates were clarified by centrifugation at 15000g for 10 min at 4°C before separation on a 10% SDS-polyacrylamide gel (PAGE) gel. For blotting analysis, gels were transferred to a nitrocellulose membrane, stained for 10 min using Ponceau S [0.1% (w/v) Ponceau S in 5% (v/ v) acetic acid/water), and blocked with "blocking buffer" (3% (w/v) BSA or 5% (w/v) milk in 0.1% Tween-20 in Tris-buffered saline] for 1 h at room temp or 4°C overnight. The blots were immersed in streptavidin−HRP in blocking buffer (Thermo Scientific, catalog no. 21126, 1:3000 dilution) at RT for 1 h and then rinsed with blocking buffer 4 times for 5 min each. For assessing comparative fragment expression level, identical gels and blots were prepared in parallel and immersed in blocking buffer containing either mouse anti-V5 (Life Technologies, catalog no. R96025, 1:10 000 dilution), mouse anti-HA (Santa Cruz Biotechnology, catalog no. G1817, 1:3000 dilution), or mouse anti-FLAG (Sigma-Aldrich, catalog no. F1804, 1:5000 dilution) for 1 h to overnight at 4°C. The blots were rinsed with blocking buffer 4 times for 5 min each before being immersed in goat anti-mouse−HRP (Bio-Rad, catalog no. 1721011, 1:3000) in blocking buffer at room temp for 1 h and then rinsed with blocking buffer 4 × 5 min again. All blots were developed using Clarity reagent (Bio-Rad) for 5 min and imaged using an Alpha Innotech gel imaging system. The quantitation of Western blots ( Figure S9C ) was performed using ImageJ on the streptavidin−HRP blot shown. The total band intensity of the entire lane, subtracting endogenously biotinylated protein bands at ∼150 and ∼90 kDa (visible in negative controls) and possible self-labeling bands at ∼58 and ∼46 kDa, was captured using ImageJ, then normalized to the amount of protein loaded (determined by intensity of lane in the Ponceau-stained blot). Because all three fragments have different epitope tags, bands were not normalized to expression of either fragment. Details are shown in Figures 3D, S9A , and S12. For visualizing the morphology of the endoplasmic reticulum, COS7 samples were prepared following the procedure for the Figure  4F samples except that two rounds of immunostaining were required. After the first round of secondary immunostaining (same antibody conditions as the MitoTracker sample), cells were washed 5 times for 5 min each prior to a second fixation with 4% formaldehyde for 25 min on ice. Cells were then blocked with 2% BSA in DPBS (w/v) for 1 h at 4°C. Afterward, a second round of primary immunostaining was performed using an antibody (Santa Cruz Biotechnology, catalog no. sc-33806, 1:1000) against the KDEL receptor, a resident ER protein, for 1 h at 4°C. After washing and secondary immunostaining with Alexa Fluor 568-goat anti-rabbit IgG (Life Technologies, catalog no. A-11011, 1:2000 dilution in 2% BSA) for 30 min at 4°C; cells were washed 5 times for 5 min each before imaging.
Fluorescence Microscopy. Confocal imaging was performed on a Zeiss AxioObserver inverted confocal microscope with a 63× oilimmersion objective, outfitted with a Yokogawa spinning disk confocal head, a Quad-band notch dichroic mirror (405/488/568/ 647), and 405 (diode), 491 (DPSS), 561 (DPSS), and 640 nm (diode) lasers (all 50 mW). CFP (405 laser excitation; 445/40 emission), Alexa Fluor 488 (491 laser excitation; 528/38 emission), Alexa Fluor 568/resorufin (561 laser excitation; 617/73 emission), Alexa Fluor 647 (647 excitation; 680/30 emission), and differential interference contrast (DIC) images were collected using Slidebook 5.0 or 6.0 software (Intelligent Imaging Innovations). Acquisition times ranged from 100 to 1000 ms. DAB labeled cells were imaged by bright field; acquisition time was 200 ms. All image analysis was performed in Slidebook. Imaging conditions and intensity scales were matched for each data set presented together.
RNA Structural Modeling. The docked four-way junction construct ("D4WJ", Figure S10B ) was designed based on analogous teco-RNA devices 96 supplemented by three-dimensional modeling as performed in COOT. 97 Briefly, parallel helices of the tetraloop− tetraloop−receptor interaction in the P4−P6 domain of the Tetrahymena thermophila group I intron 98 (PDB: 1GID) were used as structural templates on which regular A-form RNA duplexes (generated automatically in COOT) were aligned. These duplexes then served as templates on which the structures of RNA-bound MCP and PCP proteins 74, 99 (PDB IDs: 2BU1, and 2QUX, respectively) were aligned. The register of alignment (i.e., the number of base pairs between the MS2 and PP7 loops and the core four-way junction) was systematically altered so as to coproximate the N and C termini of the coat protomers while minimizing the apparent overall steric clash between the proteins. Images of the final model ( Figure S10C ) were rendered in PyMol (Schrodinger, LLC).
RNA Expression Analysis. Quantitative real-time polymerase chain reaction (RT-PCR) analysis of TERC constructs ( Figure S10D ) was performed in a manner similar to that described previously. 95 Briefly, HEK 293T cells were grown in 6-well dishes, as above, and at 80% confluency were transiently transfected with each of the TERC expression constructs using Lipofectamine 2000 (Thermo Fisher Scientific, LLC). A total of two days thereafter, cell media was aspirated, cells were washed once briefly with warmed PBS, and total cellular RNA was harvested by extraction with Trizol (Thermo Fisher) followed by precipitation with isopropanol, using Glyco Blue (Thermo Fisher) as a carrier. Pellets were resuspended in water and further purified using RNEasy mini-prep columns (QIAgen), following the manufacturer's "RNA cleanup" protocol with oncolumn DNase treatment. A total of 500 ng of purified RNA was used as a template for reverse transcription, using Super Script III Reverse Transcriptase (Thermo Fisher) primed with random hexamers (Thermo Fisher). Transcripts were quantified in quadruplicate on a 7900HT Fast RT-PCR System (Applied Biosystems) using Roxnormalized Universal SYBR Green Master Mix (Roche) and the following primers:
GAPDH_F: TTCGACAGTCAGCCGCATCTTCTT GAPDH_R: GCCCAATACGACCAAATCCGTTGA TERC_F: CGCCTTCCACCGTTCATTC TERC_R: GGCCAGCAGCTGACATTTT Data were analyzed using Realtime qPCR Miner, 100 as described previously. 95 Electron Microscopy Sample Preparation and Imaging. COS7 cells stably expressing EX-ERM under the CMV promoter were plated onto glass bottom dishes (MatTek, part no. P35GC-0− 14-C). At 70% confluence, cells were infected with lentivirus to express OMM-AP under the hUBC promoter. After 48 h, media was aspirated and replaced with 2 mL of 6 μM heme-containing cell culture media (see the Heme Supplementation and the Mammalian Cell Culture and Transfection sections for more details). After 90 min of heme incubation, heme-containing media was aspirated and replaced with 2 mL of regular cell culture media containing or omitting 400 nM rapamycin. After 30 min of rapamycin incubation, media was aspirated and replaced with 250 μL of prewarmed, 37°C 2% (v/v) glutaraldehyde (Electron Microscopy Sciences, catalog no. 16019) in sodium cacodylate buffer (100 mM sodium cacodylate, Electron Microscopy Sciences, catalog no. 12300), pH 7.4, with 2 mM calcium chloride (VWR International, catalog no. 0556-500G) to commence fixation. After 30 s, the glutaraldehyde solution was aspirated and replaced with 1.5−2 mL of fresh room-temperature 2% glutaraldehyde solution and placed on ice for 60 min. Note that all subsequent steps prior to dehydration were performed on ice. Afterward, fixation solution was removed, and cells were washed with 2 mL of cold (4°C) sodium cacodylate buffer 5 times. Cells were subsequently incubated for 5 min with 2 mL of cold 20 mM glycine (VWR International, catalog no. 470301-176) in sodium cacodylate buffer to quench unreacted glutaraldehyde and then washed with 2 mL of cold sodium cacodylate buffer 5 more times. After the 5th wash was removed, 2 mL of cold fresh DAB labeling solution was added [0.5 mg mL −1 (1.4 mM) DAB (5.4 mg mL −1 of 3,3′-diaminobenzidine, Sigma, dissolved in 0.1 M HCl) combined with 0.03% (v/v) (10 mM) H 2 O 2 in cold sodium cacodylate buffer] for 15 min. The extent of the DAB polymerization was monitored by bright field microscopy ( Figure 4G ). Cells were then washed with 2 mL of cold sodium cacodylate buffer 5 times and incubated with 2 mL of freshly prepared OsO 4 (Electron Microscopy Sciences, catalog no. 19150) in cold sodium cacodylate buffer for 30 min. OsO 4 solution was removed and transferred into sodium sulfite quenching solution (freshly prepared 0.5 M sodium sulfite; Sigma-Aldrich, catalog no. 239321). Cells were washed 5 times with 2 mL of ice-cold cell culture grade water. Cells were then incubated with 1.5 mL of cold freshly prepared 2% (w/v) uranyl acetate (Electron Microscopy Sciences, catalog no. 22400) solution for 3 h in the dark at 4°C. Cells were then washed 5 times with 2 mL of ice-cold cell culture grade water prior to dehydration via incubation with serially concentrated ethanol solutions (20%, 50%, 70%, 90%, and 100% ethanol and then 100% ethanol at room temperature). Cells were then embedded using Durcupan resin exactly as previously described. 101 Ultrathin sections were cut with a diamond knife and a Leica ultramicrotome at a thickness of 70−80 nm and examined using a FEI Technai 12 (Spirit) transmission EM operated at 120 kV equipped with a Tietz 2k by 2k CCD camera. Details are shown in Figures 4H and S14 .
We note that some optimization was required to attain PPI dependence in the EM experiment; for instance, we found it necessary to reduce overall protein expression by changing the promoter of OMM-FKBP-EX from CMV to human ubiquitin promoter (hUBC).
Yeast Strains, Transformation, and Culturing. See Supplementary Table 1 for details on all plasmids and primers used in this study. Aga2p-APEX2 (full-length) yeast and generation 2 selection yeast were generated by transformation of the yeast display plasmid pCTCON2 into the Saccharomyces cerevisiae strain EBY100. As previously reported, 38, 102 EBY100, propagated at 30°C in yeast extract peptone dextrose (YPD) complete medium, was made competent and transformed using the Frozen E-Z Yeast Transformation II Kit (Zymoprep) according to the manufacturer's protocols. Individual colonies of transformed cells containing the TRP1 gene were selected on synthetic dextrose plus casein amino acid (SDCAA) plates and propagated in SDCAA medium at 30°C. Protein expression was induced by inoculating 4.5 mL of SGCAA (SDCAA medium with dextrose replaced by an equivalent amount of galactose) with 500 μL of overnight SDCAA yeast culture and incubating at 30°C for 18−24 h. Successful incorporation was confirmed by sequencing of DNA isolated by Zymoprep (Zymoprep Yeast Plasmid Miniprep I, Zymo Research; see the modified procedure below) and FACS analysis of immunostained yeast (see the procedure below).
All other yeast used in this study were prepared using a two-step transformation of S. cerevisiae strain BJ5465, based on a previously described protocol. 38, 102 BJ5465 yeast, propagated at 30°C in YPD complete medium, were transformed first with a linearized yeast integrating plasmid (YIP) encoding Aga1p fusion constructs, plated and selected on SDCAA supplemented with 40 μg/mL tryptophan (lacking uracil). FACS analysis and DNA sequencing of PCR products amplified from extracted genomic DNA 38, 102 were used to confirm homologous recombination of the desired construct. Aga1p was constitutively expressed and immunostaining for the V5 epitope tag was detected in both SDCAA and SGCAA induction media (see Figure S4A for example of yeast surface protein and epitope tags). Next, to introduce individual Aga2p constructs to generate non-library yeast (such as starting templates and individual clones), Aga1p-fusion-expressing yeast were transformed with the applicable pCTCON2 plasmid and selected on SDCAA plates.
Generation of Yeast Libraries. For each generation of directed evolution, libraries of AP variants were generated using error-prone PCR according to published protocols. 16, 38, 62 In brief, for the generation 1 library, 150 ng of the template sAPEX AP-0 gene in pCTCON2 vector was amplified for 20 rounds with 0.4 μM forward and reverse primers, 2 mM MgCl 2 , 5 units of Taq polymerase (NEB), and 2 μM each of the mutagenic nucleotide analogs 8-oxo-2′-deoxyguanosine-5′triphosphate (8-oxo-dGTP) and 2′-deoxy-p-nucleoside-5′-triphosphate (dPTP). The PCR product was then gelpurified and amplified through 3 standard PCR reactions of 30 cycles with primers that introduce overlap to the vector, 100 μM regular dNTPs (VWR), and 5 units of Taq polymerase in a 50 μL volume. In parallel, fresh electrocompetent BJ5465 yeast constitutively expressing EX-Aga1p were prepared. BJ5465 yeast expressing EX-Aga1p were passaged at least two times before this procedure to ensure that the cells were healthy. Fresh saturated culture (3 mL) was used to inoculate 100 mL of fresh YPD media, and the cells were cultured with shaking at 220 rpm at 30°C for 6−8 h until the OD 600 reached 1.5−1.8. The cells were then harvested by centrifugation for 3 min at 3000 rpm and resuspended in 50 mL of sterile 100 mM lithium acetate in water, by vigorous shaking. Fresh sterile DTT (1 M stock solution, made on the same day) was added to the yeast cells to a final concentration of 10 mM. The cells were incubated with shaking at 220 rpm for 12 min at 30°C. Cells were then pelleted by centrifugation at 3000 rpm for 3 min at 4°C and washed once with 25 mL of ice-cold sterile water, pelleted again, and resuspended in 1 mL of ice-cold sterile water. The amplified error-prone PCR inserts were electroporated with BamHI-NheI linearized pCTCON2 vector (10 μg insert/1 μg vector) backbone into electrocompetent yeast expressing EX-Aga1p. Electroporation was performed using a Bio-Rad Gene pulser XCell with the following settings: 500 V, 15 ms pulse duration, one pulse only, 2 mm cuvette. The electroporated cells were immediately rescued with 2 mL of prewarmed YPD media and then incubated at 30°C for 1 h without shaking. Transformation efficiency was determined using 10 μL of this suspension, and the remainder was pelleted to remove the YDP media and resuspended in 100 mL of SDCAA media supplemented with 50 units of penicillin per milliliter and 50 μg/mL streptomycin. The culture was grown at 30°C with shaking at 220 rpm for 1 day before the induction of protein expression for analysis by FACS and Zymoprep. Transformation efficiency was 2.9 × 10 7 . DNA sequencing of 21 distinct colonies showed an average of 1.4 nucleotides changed per clone with a range of 0−4. For the generation 2 AP-1 library, the same procedure was employed except that electroporation was performed on S. cerevisiae EBY100. The transformation efficiency was 3.5 × 10 7 . DNA sequencing of 24 distinct colonies showed an average of 1.2 nucleotides changed per clone with a range of 0−5. For the generation 3 AP-2 library, the same procedure was employed except that the rate of mutagenesis was higher; 10 rounds of error-prone PCR were performed with 15 μM of each of the mutagenic nucleotide analogs. Electroporation was performed on BJ5465 cells stably expressing acid coil-Aga1p. Transformation efficiency was 3.1 × 10 7 . DNA sequencing of 22 distinct colonies showed an average of 7.3 nucleotides changed per clone with a range of 0−12. For generation 4 selections, a pair of libraries derived from AP-3 were combined: one generated by 10 rounds of error-prone PCR performed with 10 μM each of the mutagenic nucleotide analogs and another generated by 20 rounds of error-prone PCR performed with 4 μM each of the mutagenic nucleotide analogs. Transformation efficiencies of the respective libraries were 2.0 × 10 7 and 2.8 × 10 7 . DNA sequencing of 24 distinct colonies from each library showed an average of 5.6 and 2.9 nucleotides changed per clone, with a range of 0−9 and 0−4, respectively.
Yeast-Display Selections. For each generation of selections, yeast libraries (as described above) were induced by transferring them to 1:9 SDCAA/SGCAA media and growing the cells for 18−24 h at 30°C with shaking at 220 rpm. Overnight yeast cultures were pelleted by centrifugation (3000 rpm, room temperature, 3 min), washed with room-temperature 0.1% BSA (w/v) DPBS (DPBS-B) twice, and resuspended in an equivalent volume of DPBS-B. The OD 600 for a 1:100 dilution of the cell suspension was measured (1 OD 600 ∼ 1 × 10 7 yeast cells). An aliquot of yeast with at least a 10-fold coverage above the diversity of the yeast pool was pelleted at 7000g for 1 min. This oversampling was employed for all passaging and labeling steps except for the first-round sort of each generation, in which we aimed for 3-fold over-sampling during labeling. This lower sampling in the first round was a result of the very large diversity size and the practical difficulties and expense of labeling large numbers of yeast cells. Prior to the first round of sorting, "diversity" was considered to be the number of transformants in the initial library. In subsequent rounds, the "diversity" was the number of yeast cells collected in the previous round of sorting. Yeast libraries from generations 2−4 were first incubated with heme (see details above); to implement both the positive and negative selections, we added concentrated EX fragment (expressed and purified from Escherichia coli as described below) to the heme-containing yeast DPBS-B culture. rpm. Yeast cells were grown until saturation and passaged once more in SDCAA; depending on the number of cells collected, it took 1−2 days to reach initial saturation. Fresh saturated yeast culture (0.5 mL) was added to 4.5 mL of SGCAA for the induction, labeling, and subsequent rounds of sorting or analysis. For positive selections, trapezoidal gates were drawn to collect yeast cells positive for AF647 signal that also had high PE signal; these were the cells with a high activity-to-expression ratio. During generation 4 negative selections, generous rectangular gates were drawn to collect all AF647-positive yeast that were negative for PE signal, representative of cells with no activity despite robust expression (see Figure 2A ). We used a BD FACS Aria II cell sorter with 640 nm (for AF 647) and 488 nm or 561 nm (for PE) lasers and appropriate emission filters (780/60 for AF 647 and 575/26 for PE). Sequence Analysis of Individual Yeast Clones. Plasmid DNA from yeast cultures was harvested using the Zymoprep Yeast Plasmid Miniprep II Kit (Zymo Research) according to the manufacturer's instructions for liquid culture except for the following. Zymolyase (6 μL) was added for a total incubation time of 1−3 h, rotating at 37°C. After the addition of the manufacturer's solution 2, the mixture was briefly vortexed. DNA was eluted with 10 μL of warm water, and all eluted DNA was transformed into XL1Blue E. coli cells by heat-shock transformation and rescued for 1 h at 37°C. The entire culture was then plated on an LB-ampicillin plate, and 18−36 colonies were picked for sequencing of individual clones.
FACS Analysis. Yeast samples taken from picked colonies of transformed clones or from samples regrown after sorting were passaged in SDCAA overnight. Expression was induced by inoculating 4.5 mL of SGCAA with 500 μL of fresh saturated SDCAA yeast culture and incubating at 30°C with shaking at 220 rpm for 18−24 h. Labeling was performed as described above, and the yeast populations and clones were analyzed by FACS (BD LSR II flow cytometer, BD Biosciences) with 488 and 640 nm lasers and 582/42 (for phycoerythrin) and 670/30 (for AlexaFluor647) emission filters.
Expression and Purification of C-Terminal sAPEX Fragments (EX) from E. coli. For positive selections employed in generation 2 and negative selections in generation 4, we cloned Nterminal His6-tagged EX-flag-GFP into pYFJ16 vector for E. coli expression. For positive selections employed in generations 3 and 4, we added a base coil between the His6-tag and EX. Homemade competent BL21 cells, derived from BL21-CodonPlus (DE3)-RIPL E. coli, were transformed with pYFJ16 constructs and plated on LB-amp plates. Individual colonies were amplified in a pair of separate 5 mL cultures containing Luria−Bertani media (LB, Miller) with 100 mg/L ampicillin at 37°C overnight with shaking. The 10 mL of saturated culture was then used to inoculate 1 L of LB with 100 mg/L ampicillin, which was grown at 25°C with shaking until the OD 600 was 0.8 at 25°C. Protein expression was induced with 1 mM isopropyl β-d-1-thiogalactopyranoside (IPTG, EMD Millipore), and cultures were grown with shaking at 220 rpm at 25°C for another 20 h. Bacteria were pelleted by centrifugation at 6000 rpm for 10 min at room temperature and immediately lysed with B-PER buffer (Thermo Fisher Scientific) supplemented with 1× protease cocktail and 1 mM PMSF at 20 mL per 1 L of original culture. All subsequent steps for protein purification were performed on ice or at 4°C. The lysate was clarified by centrifugation at 10000 rpm for 15 min, and the supernatant was incubated with 1 mL of Ni-NTA agarose beads suspension (Qiagen) in binding buffer (50 mM Tris, 300 mM NaCl, pH of 7.8), in a total volume of 45 mL, for 20 min with rotation and then transferred to a gravity column. The beads were washed with 10 mL of binding buffer followed by 30 mL of washing buffer (30 mM imidazole, 50 mM Tris, 300 mM NaCl, 1 mM DTT, pH of 7.8), and then the protein was eluted with 7 mL of elution buffer (200 mM imidazole, 50 mM Tris, 300 mM NaCl, pH of 7.8). Fractions were collected and transferred to a centrifugal filter (Amicon Ultra-15) and exchanged 3 times into ice-cold DPBS and concentrated. Protein samples were flash-frozen in liquid N 2 and stored in aliquots at −80°C
. Purity was checked using SDS-PAGE. Concentrations of total protein content were determined using a bicinchoninic acid protein assay kit (Pierce).
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